alendronate has been researched along with Colorectal Neoplasms in 3 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cohort studies reporting association between alendronate or bisphosphonate therapy including alendronate in patients with osteoporosis and risk of cancer were selected by two authors." | 8.91 | The carcinogenicity of alendronate in patients with osteoporosis: evidence from cohort studies. ( Chen, LX; Cheng, L; Feng, SQ; Li, YL; Ning, GZ; Wu, QL; Zhang, D; Zhang, TS; Zhou, ZR, 2015) |
| "Cohort studies reporting association between alendronate or bisphosphonate therapy including alendronate in patients with osteoporosis and risk of cancer were selected by two authors." | 4.91 | The carcinogenicity of alendronate in patients with osteoporosis: evidence from cohort studies. ( Chen, LX; Cheng, L; Feng, SQ; Li, YL; Ning, GZ; Wu, QL; Zhang, D; Zhang, TS; Zhou, ZR, 2015) |
| "Osteopenia has received considerable attention in the past decade." | 2.41 | Neoplastic and other complications of inflammatory bowel disease. ( Bernstein, CN, 2000) |
| "The main outcome measure was colorectal cancers incidence and post-diagnosis survival in patients taking oral alendronate for osteoporosis." | 1.38 | Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study. ( Abrahamsen, B; Eastell, R; Eiken, PA; Pazianas, M; Russell, RG, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, LX | 1 |
| Ning, GZ | 1 |
| Zhou, ZR | 1 |
| Li, YL | 1 |
| Zhang, D | 1 |
| Wu, QL | 1 |
| Zhang, TS | 1 |
| Cheng, L | 1 |
| Feng, SQ | 1 |
| Pazianas, M | 1 |
| Abrahamsen, B | 1 |
| Eiken, PA | 1 |
| Eastell, R | 1 |
| Russell, RG | 1 |
| Bernstein, CN | 1 |
2 reviews available for alendronate and Colorectal Neoplasms
| Article | Year |
|---|---|
The carcinogenicity of alendronate in patients with osteoporosis: evidence from cohort studies.
Topics: Alendronate; Bone Density Conservation Agents; Cohort Studies; Colorectal Neoplasms; Female; Humans; | 2015 |
Neoplastic and other complications of inflammatory bowel disease.
Topics: Alendronate; Bone Density; Bone Diseases, Metabolic; Colitis, Ulcerative; Colorectal Neoplasms; Germ | 2000 |
1 other study available for alendronate and Colorectal Neoplasms
| Article | Year |
|---|---|
Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Colore | 2012 |